In a market that is sometimes obsessed with consumer names and high-flying tech companies, lesser-known stocks frequently go unnoticed. But among these many missed chances, three sleeper stocks have the potential to outperform the market and rise above their 52-week lows. These three equities present investors with bright growth possibilities and have quietly made big
The tech industry has experienced remarkable growth over the last several years, especially this last year. Due to its rapid innovation, it is one of the most popular industries, attracting retail and institutional investors alike. The benchmark ETF for tracking overall information technology is The Technology Select Sector SPDR Fund (NYSEARCA:XLK), which has increased by
Whispers and rumors of widespread cannabis legalization are growing louder. Although the last major surge in top cannabis stocks during the late 2010s significantly eclipses today’s market and per-share pricing, top cannabis stocks are gradually ticking upward. Recent bullish developments are both multi-pronged and global, with places like Germany and Florida moving towards more extensive
The iShares Micro-Cap ETF (NYSEARCA:IWC) has surged by approximately 20% in the past six months, illustrating the optimism among risk-seeking investors. However, key variables suggest a correction in risky asset prices might occur. For instance, the Federal Reserve has announced a reduction in its tightening program, which conveys an implied economic slowdown. Moreover, the S&P 500 Volatility
After people buy the essentials, some of their money goes toward discretionary spending. These extra purchases fuel the economy and create many jobs, but the best consumer stocks to buy can also lead to long-term wealth. Businesses have been jostling for market share and trying to attract higher percentages of consumer spending. Some corporations have
With innovations such as artificial intelligence taking the limelight, publicly traded technology enterprises have naturally accrued investor dollars. Still, a better approach may be to consider underappreciated tech stocks. Believe it or not, they do exist. Fundamentally, the biggest advantage that these less-heralded companies enjoy is lowered expectations. The challenge with the usual suspects is
The stock market has been on an incredible run over the past year with tech and growth stocks surging. Traders have piled into many fast-moving companies in hopes of locking in quick trading gains. This excitement has increasingly moved back into the meme stock arena as well. While meme stocks somewhat fell out of fashion in 2022 and 2023, they are firmly back
Investing in blockchain through cryptocurrencies is incredibly risky. The bulls will quickly point out that Bitcoin (BTC-USD) has delivered an earth-shattering return of more than 14,600% in the past decade. However, if we narrow the time horizon to 3 years, BTC has actually underperformed the S&P 500. Hence, despite the dazzling returns, BTC’s wild price swings have
From its stellar performance in 2021 to deflating in 2022, the biotech sector continued its stagnation into 2023, highlighting some pharma stocks to avoid. Year-to-date, the S&P Biotechnology Select Industry Index has dropped by 4%. Likewise, the number of biotech firms shrunk by 3% in 2023. Although overlapping with the biotech sector, pharma stocks have
Investing in stocks priced under $50 can be attractive for several reasons. Firstly, these stocks are more affordable, allowing investors to purchase more shares with less money. This can provide diversification and the potential for greater returns if the stock price rises. Secondly, lower-priced stocks can generate higher percentage returns as even small price movements